References

1. Ward A, Brogden RN, Heel RC, Speight TM, Avery GS. Isotretinoin: a review of its pharmacological properties and therapeutic efficacy in acne and related disorders. Drugs 1984; 28: 6-37

2. Harms M. Systemic isotretinoin. A unique therapeutic effect and its implications in the pathogenesis of acne. Editiones Roche, Basel, Switzerland, 1994

3. Dalziel K, Barton S, Marks R. The effect of isotreti-noin on follicular and sebaceous gland differentiation. Br J Dermatol 1987; 117:317-323

4. Cunliffe WJ, Jones DH, Pritlove J, Parkin D. Long-term benefits of isotretinoin in acne. Clinical and laboratory studies. In: Saurat JH, Ed. Retinoids: new trends in research and therapy. Karger, Basel, 1985; pp 242-251

5. Pigatto PD, Floroni A, Riva F, Brugo MA, Morandot-ti A, Altomare GF, Finzi AF. Effects of isotretinoin on the neutrophil chemotaxis in cystic acne. Dermatologica 1983; 167:16-18

6. Layton AM, Knaggs H, Taylor J, Cunliffe WJ. Isotretinoin for acne vulgaris - 10 years later: a safe and successful treatment. Br J Dermatol 1993; 129:292-296

7. Jones DH, Cunliffe WJ, King K. Hidradenitis suppurativa - lack of success with 13-cis-retinoic acid (letter). Br J Dermatol 1982; 107:252

8. Dicken CH, Powell ST, Spear KL. Evaluation of isotretinoin treatment of hidradenitis suppurativa. J Am Acad Dermatol 1984; 11:500-502

9. Norris JFB, Cunliffe WJ. Failure of treatment of familial widespread hidradenitis suppurativa with isotretinoin. Clin Exp Dermatol 1986; 11:579-583

10. Brown CF, Gallup DG, Brown VM. Hidradenitis suppurativa of the anogenital region: response to isotretinoin. Am J Obstet Gynecol 1988; 158:12-15

11. Mengesha YM, Holcombe TC, Hansen RC. Prepu-bertal hidradenitis suppurativa: two case reports and review of the literature. Pediatr Dermatol 1999; 16:292-296

12. Boer J, Gemert van MJP. Long-term results of isotretinoin in the treatment of 68 patients with hi-dradenitis suppurativa. J Am Acad Dermatol 1999; 40:73-76

13. Shalita AR, Cunningham WJ, Leyden JJ, Pochi PE, Strauss JS. Isotretinoin treatment of acne and related disorders: an update. J Am Acad Dermatol 1983; 9:629-638

14. Leyden JJ. Oral isotretinoin. How can we treat difficult acne patients? Dermatology 1997; 195 [Suppl 1]:29-33

15. Webster GF. Acne vulgaris. Br Med J 2002; 325:475479

16. Jansen T, Altmeyer P, Plewig G. Acne inversa (alias hidradenitis suppurativa). J Eur Acad Dermatol Ve-nereol 2002; 15:532-540

17. Jemec GBE. Medical treatment of hidradenitis suppurativa. Expert Opin Pharmacother 2004; 5:17671770

18. Jones H, Blanc D, Cunliffe WJ. 13-cis-retinoic acid and acne. Lancet 1983; ii:1048-1049

19. Plewig G, Nikolowsky J, Wolff HH. Action of iso-tretinoin in acne rosacea and gram-negative fol-liculitis. J Am Acad Dermatol 1982; 6:766-785

20. Peck GL, Olsen TG, Butkus D, Pandya M, Arn-aud-Battandier J. Isotretinoin versus placebo in the treatment of cystic acne. J Am Acad Dermatol 1982; 6:735-745

21. Harms M. Traitement de l'acne par l'isotretino'ine par voie buccale. Etude clinique sur 56 patients. Schweiz Med Wschr 1983; 42:1549-1554

22. Libow LF, Friar DA. Arthropathy associated with cystic acne, hidradenitis suppurativa, and perifol-liculitis capitis abscedens et suffodiens: treatment with isotretinoin. Cutis 1999; 64:87-90

23. Jemec GBE. Hidradenitis suppurativa. J Cutan Med Surg 2003; 7(1):47-56

24. Plewig G, Steger M. Acne inversa (alias acne triad, acne tetrad or hidradenitis suppurativa). In: Marks R, Plewig G, Eds. Acne and related disorders. Martin Dunitz, London, 1989; pp 345-538

25. Rödder-Wehrmann O, Küster W, Plewig G. Acne inversa. Diagnose und therapie. Hautarzt 1991; 42:58

26. Hermann A, Preusser KP, Marsch WC. Die Acne inversa Hidradenitis suppurativa): Frühzeitig erkennen und kurativ operieren. Chirurg 2000; 71:13951400

27. Lentner A, Rübben A, Wienert V. Klinische Erscheinungsbild und Tharapie der Pyodermia fistu-lans significa. Symptomatology and therapy of hidradenitis suppurativa. Z Hautkr 1992; 67:988-992

28. Tsianos EV, Dalekos GN, Tzermias C, Merkouro-poulos M, Hatzis J. Hidradenitis suppurativa in Crohn's disease. J Clin Gastroenterol 1995; 20:151153

29. Fearfield LA, Staughton RCD. Severe vulval apo-crine acne successfully treated with prednisolone and isotretinoin. Clin Exp Dermatol 1998; 24:189192

30. Saurat JH. Side effects of systemic retinoids and their clinical management. J Am Acad Dermatol 1992; 27:S23-S28

31. Barth JH, Macdonald-Hull SP, Mark J, Jones RG, Cunliffe WJ. Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests. Br J Dermatol 1993; 129:704-707

32. Perlman SE, Leach EE, Dominguez L, Ruszkowski AM, Rudy SJ. Be smart, be safe, be sure. The revised pregnancy prevention program for woman on isotretinoin. J Reprod Med 2001; 46:179-185

33. Pilkington T, Brogden RN. Acitretin. A review on its pharmacology and therapeutic use. Drugs 1992; 43:597-627

34. Stewart WD. Etretinate in other diseases of kera-tinization. In: The retinoids: a significant advance in dermatology. Medicines Publishing Foundation Symposium Series, Oxford, 1984; Series 14:51-55

35. Hogan DJ, Light MJ. Successful treatment of hidra-denitis suppurativa with acitretin. J Am Acad Der-matol 1988; 19:355-356

36. Vahlquist A, Griffiths WAD. Retinoid therapy in hidradenitis suppurativa - report of a case. Retinoids Today Tom 1990; 18:28-30

37. Chow ETY, Mortimer PS. Successful treatment of hidradenitis suppurativa and retroauricular acne with etretinate. Br J Dermatol 1992; 126:415

38. Scheman AJ. Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report. Cutis 2002; 69:287-288

39. Shalita AR, Fritsch PO. Retinoids: present and future. J Am Acad Dermatol 1992; 27:S1-S46

40. Katz HI, Waalen J, Leach EE. Acitretin for psoriasis therapy. J Am Acad Dermatol 1998; 41:S7-S12

41. Lowe NJ. Psoriasis: systemic retinoid treatment. In: Lowe N, Marks R, Eds. Retinoids. A clinician's guide, 2nd edn. Martin Dunitz, London, 1998; pp 57-69

Natural Treatments For Psoriasis

Natural Treatments For Psoriasis

Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.

Get My Free Ebook


Post a comment